Oroxin B Attenuates Ovariectomy-Induced Bone Loss by Suppressing Osteoclast Formation and Activity

References

• SvedbomA, HernlundE, IvergårdM, et al. Osteoporosis in the European Union: a compendium of country-specific reports. Arch Osteoporos. 2013;8(1–2):137. doi:10.1007/s11657-013-0137-024113838
   PubMed Web of Science ®Google Scholar
• LaneNE. Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol. 2006;194(2 Suppl):S3–11. doi:10.1016/j.ajog.2005.08.04716448873
   PubMed Web of Science ®Google Scholar
• WangT, LiuQ, ZhouL, et al. Andrographolide inhibits ovariectomy-induced bone loss via the suppression of RANKL signaling pathways. Int J Mol Sci. 2015;16(11):27470–27481. doi:10.3390/ijms16112603926593901
   PubMed Web of Science ®Google Scholar
• XuH, LiuT, JiaY, et al. (-)-Epigallocatechin-3-gallate inhibits osteoclastogenesis by blocking RANKL-RANK interaction and suppressing NF-κB and MAPK signaling pathways. Int Immunopharmacol. 2021;95:107464. doi:10.1016/j.intimp.2021.10746433677256
   PubMed Web of Science ®Google Scholar
• MunSH, ParkPSU, Park-MinKH. The M-CSF receptor in osteoclasts and beyond. Exp Mol Med. 2020;52(8):1239–1254. doi:10.1038/s12276-020-0484-z32801364
   PubMed Web of Science ®Google Scholar
• LeeSE, ChungWJ, KwakHB, et al. Tumor necrosis factor-alpha supports the survival of osteoclasts through the activation of Akt and ERK. J Biol Chem. 2001;276(52):49343–49349. doi:10.1074/jbc.M10364220011675379
   PubMed Web of Science ®Google Scholar
• TakayanagiH, KimS, KogaT, et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. 2002;3(6):889–901. doi:10.1016/s1534-5807(02)00369-612479813
   PubMed Web of Science ®Google Scholar
• JiangL, NumonovS, BobakulovK, QureshiMN, ZhaoH, AisaHA. Phytochemical profiling and evaluation of pharmacological activities of Hypericum scabrum L. Molecules. 2015;20(6):11257–11271. doi:10.3390/molecules20061125726096433
   PubMed Web of Science ®Google Scholar
• MoriT, KobayashiH, OnoR, TajimaT. [Therapeutic result and roentgenological prognosis of cervical spondylosis after Cloward surgery]. Seikei Geka. 1970;21(8):618–625. Japanese.5465813
   PubMedGoogle Scholar
• NijveldtRJ, van NoodE, van HoornDE, BoelensPG, van NorrenK, van LeeuwenPA. Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr. 2001;74(4):418–425. doi:10.1093/ajcn/74.4.41811566638
   PubMed Web of Science ®Google Scholar
• ZhangX, LiuT, HuangY, WismeijerD, LiuY. Icariin: does it have an osteoinductive potential for bone tissue engineering? Phytother Res. 2014;28(4):498–509. doi:10.1002/ptr.502723824956
   PubMed Web of Science ®Google Scholar
• WangZ, WangD, YangD, ZhenW, ZhangJ, PengS. The effect of icariin on bone metabolism and its potential clinical application. Osteoporosis Int. 2018;29(3):535–544. doi:10.1007/s00198-017-4255-1
   PubMed Web of Science ®Google Scholar
• HuangJM, BaoY, XiangW, et al. Icariin regulates the bidirectional differentiation of bone marrow mesenchymal stem cells through canonical Wnt signaling pathway. eCAM. 2017;2017:8085325. doi:10.1155/2017/808532529445413
   PubMed Web of Science ®Google Scholar
• ZhuW, YinZ, ZhangQ, et al. Proanthocyanidins inhibit osteoclast formation and function by inhibiting the NF-κB and JNK signaling pathways during osteoporosis treatment. Biochem Biophys Res Commun. 2019;509(1):294–300. doi:10.1016/j.bbrc.2018.12.12530583865
   PubMed Web of Science ®Google Scholar
• LeeJ, NohAL, ZhengT, KangJH, YimM. Eriodicyol inhibits osteoclast differentiation and ovariectomy-induced bone loss in vivo. Exp Cell Res. 2015;339(2):380–388. doi:10.1016/j.yexcr.2015.10.00126450448
   PubMed Web of Science ®Google Scholar
• LuL, RaoL, JiaH, et al. Baicalin positively regulates osteoclast function by activating MAPK/Mitf signalling. J Cell Mol Med. 2017;21(7):1361–1372. doi:10.1111/jcmm.1306628158928
   PubMed Web of Science ®Google Scholar
• QiuJ, WangD, ZhangY, DongJ, WangJ, NiuX. Molecular modeling reveals the novel inhibition mechanism and binding mode of three natural compounds to staphylococcal α-hemolysin. PLoS One. 2013;8(11):e80197. doi:10.1371/journal.pone.008019724312202
   PubMed Web of Science ®Google Scholar
• YangP, FuS, CaoZ, et al. Oroxin B selectively induces tumor-suppressive ER stress and concurrently inhibits tumor-adaptive ER stress in B-lymphoma cells for effective anti-lymphoma therapy. Toxicol Appl Pharmacol. 2015;288(2):269–279. doi:10.1016/j.taap.2015.07.02626253462
   PubMed Web of Science ®Google Scholar
• LiNN, MengXS, BaoYR, WangS, LiTJ. Evidence for the Involvement of COX-2/VEGF and PTEN/Pl3K/AKT pathway the mechanism of oroxin b treated liver cancer. Pharmacogn Mag. 2018;14(54):207–213. doi:10.4103/pm.pm_119_1729720833
   PubMed Web of Science ®Google Scholar
• LiN, MenW, ZhengY, WangH, MengX. Oroxin B induces apoptosis by down-regulating MicroRNA-221 resulting in the inactivation of the PTEN/PI3K/AKT pathway in liver cancer. Molecules. 2019;24(23):4384. doi:10.3390/molecules24234384
   Web of Science ®Google Scholar
• GuanH, ZhaoL, CaoH, ChenA, XiaoJ. Epoxyeicosanoids suppress osteoclastogenesis and prevent ovariectomy-induced bone loss. FASEB j. 2015;29(3):1092–1101. doi:10.1096/fj.14-26205525466887
   PubMed Web of Science ®Google Scholar
• SakaiA, NishidaS, NishidaS, et al. 1alpha-Hydroxyvitamin D3 suppresses trabecular bone resorption by inhibiting osteoclastogenic potential in bone marrow cells after ovariectomy in mice. J Bone Miner Metab. 2001;19(5):277–286. doi:10.1007/s00774017001111498729
   PubMed Web of Science ®Google Scholar
• ZhanY, LiangJ, TianK, et al. Vindoline Inhibits RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss in mice. Front Pharmacol. 2019;10:1587. doi:10.3389/fphar.2019.0158732038256
   PubMed Web of Science ®Google Scholar
• JeongE, ChoiHK, ParkJH, LeeSY. STAC2 negatively regulates osteoclast formation by targeting the RANK signaling complex. Cell Death Differ. 2018;25(8):1364–1374. doi:10.1038/s41418-017-0048-529348675
   PubMed Web of Science ®Google Scholar
• LalrinzualiK, VabeiryureilaiM, JagetiaGC. Topical application of stem bark ethanol extract of Sonapatha, Oroxylum indicum (L.) Kurz accelerates healing of deep dermal excision wound in Swiss albino mice. J Ethnopharmacol. 2018;227:290–299. doi:10.1016/j.jep.2018.08.01830121235
   PubMed Web of Science ®Google Scholar
• DoshiK, IlanchezhianR, AcharyaR, PatelBR, RavishankarB. Anti-inflammatory activity of root bark and stem bark of Shyonaka. J Ayurveda Integr Med. 2012;3(4):194–197. doi:10.4103/0975-9476.10443423326090
   PubMedGoogle Scholar
• SiriwatanametanonN, FiebichBL, EfferthT, PrietoJM, HeinrichM. Traditionally used Thai medicinal plants: in vitro anti-inflammatory, anticancer and antioxidant activities. J Ethnopharmacol. 2010;130(2):196–207. doi:10.1016/j.jep.2010.04.03620435130
   PubMed Web of Science ®Google Scholar
• ZaveriM, GohilP, JainS. Immunostimulant activity of n-butanol fraction of root bark of Oroxylum indicum, vent. J Immunotoxicol. 2006;3(2):83–99. doi:10.1080/1547691060072594218958688
   PubMedGoogle Scholar
• Nik SallehNNH, OthmanFA, KamarudinNA, TanSC. The biological activities and therapeutic potentials of baicalein extracted from oroxylum indicum: a systematic review. Molecules. 2020;25(23):5677. doi:10.3390/molecules25235677
   PubMed Web of Science ®Google Scholar
• PearsonG, RobinsonF, Beers GibsonT, et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev. 2001;22(2):153–183. doi:10.1210/edrv.22.2.042811294822
   PubMed Web of Science ®Google Scholar
• Abu-AmerY. NF-κB signaling and bone resorption. Osteoporosis Int. 2013;24(9):2377–2386. doi:10.1007/s00198-013-2313-x
   PubMed Web of Science ®Google Scholar
• LeeMS, KimHS, YeonJT, et al. GM-CSF regulates fusion of mononuclear osteoclasts into bone-resorbing osteoclasts by activating the Ras/ERK pathway. J Immunol. 2009;183(5):3390–3399. doi:10.4049/jimmunol.080431419641137
   PubMed Web of Science ®Google Scholar
• ChangEJ, HaJ, HuangH, et al. The JNK-dependent CaMK pathway restrains the reversion of committed cells during osteoclast differentiation. J Cell Sci. 2008;121(Pt 15):2555–2564. doi:10.1242/jcs.02821718650497
   PubMed Web of Science ®Google Scholar
• KrumSA. Direct transcriptional targets of sex steroid hormones in bone. J Cell Biochem. 2011;112(2):401–408. doi:10.1002/jcb.2297021268060
   PubMed Web of Science ®Google Scholar
• KimK, KimJH, LeeJ, et al. Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis. J Biol Chem. 2005;280(42):35209–35216. doi:10.1074/jbc.M50581520016109714
   PubMed Web of Science ®Google Scholar
• KimY, SatoK, AsagiriM, MoritaI, SomaK, TakayanagiH. Contribution of nuclear factor of activated T cells c1 to the transcriptional control of immunoreceptor osteoclast-associated receptor but not triggering receptor expressed by myeloid cells-2 during osteoclastogenesis. J Biol Chem. 2005;280(38):32905–32913. doi:10.1074/jbc.M50582020016046394
   PubMed Web of Science ®Google Scholar
• EdwardsJR, MundyGR. Advances in osteoclast biology: old findings and new insights from mouse models. Nat Rev Rheumatol. 2011;7(4):235–243. doi:10.1038/nrrheum.2011.2321386794
   PubMed Web of Science ®Google Scholar
• WinslowMM, PanM, StarbuckM, et al. Calcineurin/NFAT signaling in osteoblasts regulates bone mass. Dev Cell. 2006;10(6):771–782. doi:10.1016/j.devcel.2006.04.00616740479
   PubMed Web of Science ®Google Scholar
• KimJH, KimN. Regulation of NFATc1 in osteoclast differentiation. J Bone Metab. 2014;21(4):233–241. doi:10.11005/jbm.2014.21.4.23325489571
   PubMedGoogle Scholar
• El KholyK, FreireM, ChenT, Van DykeTE. Resolvin E1 promotes bone preservation under inflammatory conditions. Front Immunol. 2018;9:1300. doi:10.3389/fimmu.2018.0130029946319
   PubMed Web of Science ®Google Scholar